SenesTech, Inc. (/sɛnɛstɛk/) is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| SNES | SenesTech, Inc. | 2026-04-02 15:10:04 | 1.62 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNES | 0001680378 | SenesTech, Inc. | US81720R6045 | 549300YVNQPK8VJ8TT73 | 202079805 | Nasdaq | 2870 | Agricultural Chemicals | 1231 | DE | 777 W. PINNACLE PEAK ROAD | PHOENIX | AZ | 85027 | UNITED STATES | US | (928) 779 - 4143 | PO BOX 3627, FLAGSTAFF, AZ, 86003 | 777 W. PINNACLE PEAK ROAD, PHOENIX, AZ, 85027 | — | Biotechnology | 2004 | Joel Fruendt | 33 | https://senestech.com/ | 19,159,000 | 5,223,015 | 5,303,426 | SenesTech, Inc. (/sɛnɛstɛk/) is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona. | 2026-04-02 20:31:05 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 19,159,000 | 16,191,000 | 545.5189 | 5,303,426 | 3,556,496 | 203.5855 |
| 2024 | 2,968,000 | -352,000 | -10.6024 | 1,746,930 | -3,397,702 | -66.0436 |
| 2023 | 3,320,000 | -3,122,000 | -48.4632 | 5,144,632 | 3,091,759 | 150.6064 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Thomas C. Chesterman | Chief Financial Officer, Secretary, Treasurer, Executive Vice President | 2024 | 261,458 | 30,000 | 0 | — | 7,195 | 364,178 |
| Joel L. Fruendt | Chief Executive Officer, President | 2024 | 344,875 | 75,000 | 0 | — | 3,044 | 575,809 |
| Joel L. Fruendt | Chief Executive Officer, President | 2023 | 340,000 | 0 | 0 | — | 3,044 | 343,044 |
| Thomas C. Chesterman | Chief Financial Officer, Secretary, Treasurer, Executive Vice President | 2023 | 250,000 | 0 | 0 | — | 11,431 | 261,431 |
| Nicole C. Williams | Chief Revenue Officer | 2023 | 72,310 | 0 | 0 | — | 111,722 | 184,032 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 23 |
| 2024 | 23 |
| 2023 | 25 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 2,221,000 | 1,857,000 | 1,193,000 |
| Cost Of Revenue | 833,000 | 853,000 | 654,000 |
| Gross Profit | 1,388,000 | 1,004,000 | 539,000 |
| Research And Development Expenses | 1,698,000 | 1,712,000 | 1,228,000 |
| General And Administrative Expenses | 6,195,000 | 5,541,000 | 7,043,000 |
| Operating Expenses | 7,893,000 | 7,253,000 | 8,271,000 |
| Operating Income | -6,505,000 | -6,249,000 | -7,732,000 |
| Net Income | -6,383,000 | -6,184,000 | -7,710,000 |
| Earnings Per Share Basic | -1.95 | -8.86 | -11.51 |
| Earnings Per Share Diluted | -1.95 | -8.86 | -11.51 |
| Weighted Average Shares Outstanding Basic | 3,275,983 | 697,974 | 669,861 |
| Weighted Average Shares Outstanding Diluted | 3,275,983 | 697,974 | 669,861 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 7,575,000 | 1,307,000 | 5,395,000 |
| Marketable Securities Current | 994,000 | — | — |
| Accounts Receivable | 201,000 | 335,000 | 95,000 |
| Inventories | 994,000 | 794,000 | 795,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 297,000 | 377,000 | 388,000 |
| Total Assets Current | 10,061,000 | 2,813,000 | 6,673,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 410,000 | 407,000 | 388,000 |
| Other Assets Non Current | 36,000 | 58,000 | 22,000 |
| Total Assets Non Current | 2,782,000 | 465,000 | 620,000 |
| Total Assets | 12,843,000 | 3,278,000 | 7,293,000 |
| Accounts Payable | 183,000 | 215,000 | 150,000 |
| Deferred Revenue | 32,000 | 12,000 | 18,000 |
| Short Term Debt | 61,000 | 56,000 | 33,000 |
| Other Liabilities Current | 383,000 | 278,000 | 368,000 |
| Total Liabilities Current | 798,000 | 561,000 | 786,000 |
| Long Term Debt | 206,000 | 262,000 | 189,000 |
| Other Liabilities Non Current | — | — | — |
| Total Liabilities Non Current | 2,477,000 | 206,000 | 156,000 |
| Total Liabilities | 3,275,000 | 767,000 | 942,000 |
| Common Stock | 5,000 | 1,000 | 5,000 |
| Retained Earnings | -142,480,000 | -136,097,000 | -129,913,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 9,568,000 | 2,511,000 | 6,351,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 135,000 | 156,000 | 135,000 |
| Share Based Compensation Expense | 264,000 | 326,000 | 555,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -121,000 | 242,000 | -20,000 |
| Change In Inventories | 200,000 | -1,000 | -58,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -22,000 | 44,000 | 4,000 |
| Change In Accounts Payable | -32,000 | 65,000 | -390,000 |
| Change In Other Liabilities | 105,000 | -90,000 | -192,000 |
| Cash From Operating Activities | -5,750,000 | -6,033,000 | -7,566,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 138,000 | 84,000 | 149,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -1,102,000 | -56,000 | -149,000 |
| Tax Withholding For Share Based Compensation | — | 0 | 11,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 2,706,000 | 38,000 | 5,407,000 |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 13,120,000 | 2,001,000 | 8,335,000 |
| Change In Cash | 6,268,000 | -4,088,000 | 620,000 |
| Cash At End Of Period | 7,575,000 | 1,307,000 | 5,395,000 |
| Income Taxes Paid | 0 | 0 | 0 |
| Interest Paid | 22,000 | 22,000 | 4,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -1.95 | -8.86 | -11.51 |
| Price To Earnings Ratio | -1.0974 | -0.3736 | -1.1034 |
| Earnings Growth Rate | -77.991 | -23.0235 | -25.7419 |
| Price Earnings To Growth Ratio | 0.0141 | 0.0162 | 0.0429 |
| Book Value Per Share | 2.9207 | 3.5976 | 9.4811 |
| Price To Book Ratio | 0.7327 | 0.9201 | 1.3395 |
| Ebitda | -6,226,000 | -6,006,000 | -7,571,000 |
| Enterprise Value | -297,396.38 | 1,321,293.94 | 3,334,234.7 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.0279 | 0.1266 | 0.035 |
| Capital Expenditures | 138,000 | 175,000 | 229,000 |
| Free Cash Flow | -5,888,000 | -6,208,000 | -7,795,000 |
| Return On Equity | -0.6671 | -2.4628 | -1.214 |
| One Year Beta | 1.9623 | 0.434 | 0.6157 |
| Three Year Beta | 1.2602 | 0.5257 | 0.5747 |
| Five Year Beta | 0.9034 | 0.31 | 0.3204 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| GLENBROOK CAPITAL MANAGEMENT | 10% owner | 2026-03-17 | 19,725 | A | 890,635 |
| GLENBROOK CAPITAL MANAGEMENT | 10% owner | 2026-03-16 | 5,060 | A | 870,910 |
| GLENBROOK CAPITAL MANAGEMENT | 10% owner | 2026-03-13 | 146,249 | A | 865,850 |
| GLENBROOK CAPITAL MANAGEMENT | 10% owner | 2026-02-19 | 34,613 | A | 704,211 |
| GLENBROOK CAPITAL MANAGEMENT | 10% owner | 2026-02-18 | 10,481 | A | 669,598 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 2025-12-31 | 167,645 | 78,339 | 2.14 |
| MILLENNIUM MANAGEMENT LLC | 2025-12-31 | 29,027 | 13,564 | 2.14 |
| BANK OF AMERICA CORP /DE/ | 2025-12-31 | 100 | 47 | 2.1277 |
| XTX Topco Ltd | 2025-12-31 | 54,084 | 25,273 | 2.14 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 2025-12-31 | 81,675 | 38,166 | 2.14 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 2025-12-31 | Class K | SSBIX | 652 | 1,395.28 | 0.0002 |
| VANGUARD INDEX FUNDS | 2025-12-31 | Institutional Select Shares | VSTSX | 1,900 | 4,066 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | Institutional Plus Shares | VSMPX | 1,900 | 4,066 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | ETF Shares | VTI | 1,900 | 4,066 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | Institutional Shares | VITSX | 1,900 | 4,066 | 0.0 |